Evidence map›Paper›PMID 32193753›Full record

ReviewNeurochemical research2021

The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.

João Laranjinha, Carla Nunes, Ana Ledo, Cátia Lourenço, Bárbara Rocha, Rui M Barbosa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

João LaranjinhaFaculty of Pharmacy, University of Coimbra, Azinhaga Sta. Comba, 3000-548, Coimbra, Portugal. laranjin@ci.uc.pt.ORCID https://orcid.org/0000-0003-4370-5177
Carla NunesFaculty of Pharmacy, University of Coimbra, Azinhaga Sta. Comba, 3000-548, Coimbra, Portugal.
Ana LedoCenter for Neuroscience and Cell Biology, University of Coimbra, Pólo 1, 3000-504, Coimbra, Portugal.
Cátia LourençoCenter for Neuroscience and Cell Biology, University of Coimbra, Pólo 1, 3000-504, Coimbra, Portugal.
Bárbara RochaFaculty of Pharmacy, University of Coimbra, Azinhaga Sta. Comba, 3000-548, Coimbra, Portugal.
Rui M BarbosaFaculty of Pharmacy, University of Coimbra, Azinhaga Sta. Comba, 3000-548, Coimbra, Portugal.
University of Coimbra · PT

Funding

This work was financed by the European Regional Development Fund (FEDER) funds through the Operational Program for Competitiveness and Internationalization - COMPETE and national funds by FCT - Foundation for Science and Technology under the project POCI-0 POCI-01-0145-FEDER-029099
6 · The paper itself

Abstract

In this review, we address the regulatory and toxic role of

Indexed as

3,4-Dihydroxyphenylacetic AcidAlzheimer DiseaseAnimalsBrainEnergy MetabolismHumansMitochondriaNeurovascular CouplingNitric OxideParkinson DiseaseSignal Transduction3,4-Dihydroxyphenylacetic AcidNitric OxideBrain metabolismMitochondrial respirationNeurodegenerative diseasesNeurovascular couplingNitrate and nitriteNitric oxideRedox signaling

Identifiers

PMID32193753
OpenAlexW3012066498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.